[HTML][HTML] Current status of canine melanoma diagnosis and therapy: report from a colloquium on canine melanoma organized by ABROVET (Brazilian Association of …
CE Fonseca-Alves, Ê Ferreira… - Frontiers in Veterinary …, 2021 - frontiersin.org
Melanoma is a prevalent, aggressive form of cancer in dogs. New treatment or preventive
modalities are necessary to control this disease in dogs. On December 03, 2020, the …
modalities are necessary to control this disease in dogs. On December 03, 2020, the …
Perspectives for combining viral oncolysis with additional immunotherapies for the treatment of melanoma
OLD Cerqueira, F Antunes, NG Assis… - Frontiers in Molecular …, 2022 - frontiersin.org
Melanoma is the deadliest type of skin cancer with steadily increasing incidence worldwide
during the last few decades. In addition to its tumor associated antigens (TAAs), melanoma …
during the last few decades. In addition to its tumor associated antigens (TAAs), melanoma …
Combined p14ARF and Interferon-β Gene Transfer to the Human Melanoma Cell Line SK-MEL-147 Promotes Oncolysis and Immune Activation
OLD Cerqueira, MA Clavijo-Salomon… - Frontiers in …, 2020 - frontiersin.org
Immune evasion is an important cancer hallmark and the understanding of its mechanisms
has generated successful therapeutic approaches. Induction of immunogenic cell death …
has generated successful therapeutic approaches. Induction of immunogenic cell death …
Induction of Immune-Stimulating Factors and Oncolysis Upon p14ARF Gene Transfer in Melanoma Cell Lines
SA Mendonça, F Antunes, OLD Cerqueira… - DNA and cell …, 2023 - liebertpub.com
Together with an anti-tumor immune response, oncolysis using a recombinant viral vector
promises to eliminate cancer cells by both gene transfer and host-mediated functions. In this …
promises to eliminate cancer cells by both gene transfer and host-mediated functions. In this …
Exploration of p53 plus interferon-beta gene transfer for the sensitization of human colorectal cancer cell lines to cell death
PR Del Valle, SA Mendonça, F Antunes… - Cancer Biology & …, 2021 - Taylor & Francis
While treatments for colorectal cancer continue to improve, some 50% of patients succumb
within 5 years, pointing to the need for additional therapeutic options. We have developed a …
within 5 years, pointing to the need for additional therapeutic options. We have developed a …